ElectroCore Supports Results of Lancet Paper Highlighting the Benefits of Vagus Nerve Stimulation for Stroke Patients

electroCore, Inc., a commercial-stage bioelectronic medicine company, commends the results of the VNS-REHAB study published in the April 24th edition of The Lancet which demonstrated how vagus nerve stimulation (VNS) during rehabilitation can significantly improve arm function after an ischemic stroke. Effective treatments hold particular interest because stroke is the second highest cause of death and the third leading cause of disability globally, with ischemic stroke as the most common type of stroke. The results of the VNS-REHAB study build general excitement for the medical and scientific community’s ongoing efforts to find new and safe ways to treat the immediate or long-term disabilities faced by stroke patients.

By clicking “Accept” you are agreeing to eletroCore to place cookies on your browser to gather web statistics that help us improve our site experience. Please read our Privacy Policy for more information on the types of cookies we use.